Quyen Schwing

Quyen Schwing possesses extensive experience in pharmaceutical formulation and research, having held roles at notable companies such as Ashland, IGI Laboratories, and Elan Drug Technologies. At Ashland, Quyen served as a Senior Team Leader and Research Scientist, focusing on polymeric products and new functional excipients. Prior experience includes developing generic semi-solid medicated formulations at IGI Laboratories and Elan Drug Technologies, with responsibilities encompassing quantitative composition determination and ANDA documentation. Additional roles involved formulation process development for marketed products and microbiological research at Temple University Hospital and the American Red Cross. Quyen's expertise spans various formulation techniques, project management, and client support in the pharmaceutical industry.